
Intralytix, Inc. is a privately owned biotech venture incorporated in the State of Maryland on July 28, 1998. Intralytix specializes in bacteriophage based products used to control bacterial pathogens in environmental, agricultural, food processing, and medical settings. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intralytix (United States), United States, covering academic research published from 2003 to 2025. Read More.
Open Access Percentage
73%
Total
Publications
103
Total Open
Publications
75
Total
Citations
5.4K
Open Access
Percentage
73%
Total
Publications
103
Total Open
Publications
75
Total
Citations
5.4K
Breakdown
Publisher Open
25%
Both
37%
Other Platform Open
11%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 58%
38
Hybrid 11%
7
No Guarantees 31%
20
Other Platform Open
Domain 69%
35
Institution 51%
26
Other Internet 16%
8
Preprint 12%
6
Public 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 35 |
doaj.org OAI-PMH Repository | Institution | 16 |
Vrije Universiteit Amsterdam | Institution | 6 |
DOI | Other Internet | 5 |
bioRxiv | Preprint | 5 |
University of Copenhagen | Institution | 4 |
Unknown Repository | Other Internet | 3 |
Office of Scientific and Technical Information | Institution | 2 |
Europe PMC | Domain | 2 |
Teagasc - The Irish Agriculture and Food Development Authority | Institution | 1 |